This chemistry question involves key chemical concepts and calculations. The detailed solution below walks through each step, from identifying the reaction type to computing the final answer.
ScanSolve AI Answer
Here is information on each of the requested medications: Vitamin K Function: Essential for the synthesis of several blood clotting factors (II, VII, IX, X) and anticoagulant proteins (C and S) in the liver. It is used to reverse the effects of certain anticoagulants (like warfarin) and to treat vitamin K deficiency bleeding. Route of Administration: Oral, subcutaneous (SC), intramuscular (IM), intravenous (IV). Mechanism: Acts as a cofactor for the enzyme γ-glutamyl carboxylase, which is necessary for the post-translational carboxylation of specific glutamic acid residues on clotting factors. This carboxylation allows these factors to bind calcium and become biologically active. Dosage: Varies by indication. For warfarin reversal:* Typically 2.5-10 mg orally or IV. For neonates (prophylaxis):* 0.5-1 mg IM. Heparin Function: An anticoagulant* that prevents the formation of new blood clots and the extension of existing clots. It does not dissolve existing clots. Route of Administration: Subcutaneous (SC), intravenous (IV). It is not given intramuscularly due to the risk of hematoma formation.* Mechanism: Binds to and activates antithrombin III (ATIII)*, a natural anticoagulant. The activated ATIII then inactivates key clotting factors, primarily thrombin (Factor IIa) and Factor Xa, thereby interrupting the coagulation cascade and preventing fibrin formation. Dosage: Highly variable based on indication and patient weight. For prophylaxis against DVT/PE:* Typically 5,000 units SC every 8-12 hours. For treatment of DVT/PE (IV infusion):* Initial bolus (e.g., 80 units/kg) followed by a continuous infusion (e.g., 18 units/kg/hour), adjusted based on activated partial thromboplastin time (aPTT). Morphine Function: A potent opioid analgesic* used to relieve moderate to severe acute and chronic pain. It also produces sedation and euphoria. Route of Administration: Oral, intravenous (IV), intramuscular (IM), subcutaneous (SC), rectal, epidural, intrathecal. Mechanism: Acts primarily as an agonist at μ-opioid receptors* in the central nervous system (CNS), spinal cord, and peripheral tissues. Binding to these receptors inhibits the transmission of pain signals, alters the perception of pain, and reduces the emotional response to pain. Dosage: Highly variable based on pain severity, patient tolerance, and route. IV (acute pain):* Typically 2-10 mg every 3-4 hours, titrated to effect. Oral (immediate release):* Typically 10-30 mg every 4 hours. Aspirin (Acetylsalicylic Acid) Function: Has multiple functions: antiplatelet (prevents blood clots), analgesic (pain relief), antipyretic (reduces fever), and anti-inflammatory*. Route of Administration: Oral, rectal. Mechanism: Antiplatelet: Irreversibly inhibits cyclooxygenase-1 (COX-1) in platelets, which prevents the synthesis of thromboxane A₂ (TXA₂)*. TXA₂ is a potent platelet aggregator and vasoconstrictor, so inhibiting it reduces platelet aggregation and clot formation. This effect lasts for the lifetime of the platelet (7-10 days). Analgesic/Antipyretic/Anti-inflammatory: Inhibits both COX-1 and COX-2 enzymes, reducing the production of prostaglandins*, which are mediators of pain, fever, and inflammation. Dosage: Antiplatelet (cardioprotection):* Typically 75-325 mg orally once daily (commonly 81 mg or 162 mg). Analgesic/Antipyretic:* Typically 325-650 mg orally every 4-6 hours. Tranexamic Acid Function: An antifibrinolytic* agent used to reduce or prevent excessive bleeding by stabilizing blood clots. Route of Administration: Intravenous (IV), Oral. Mechanism: Competitively inhibits the activation of plasminogen to plasmin*. Plasmin is an enzyme responsible for breaking down fibrin clots (fibrinolysis). By inhibiting plasmin, tranexamic acid prevents the premature breakdown of clots, thereby reducing bleeding. Dosage: Varies by indication. For trauma (IV):* Typically 1 gram IV over 10 minutes, followed by 1 gram IV over 8 hours. For menorrhagia (oral):* Typically 1-1.5 grams orally 3-4 times daily for 3-5 days during menstruation. 3 done, 2 left today. You're making progress.